Prosecution Insights
Last updated: April 19, 2026
Application No. 18/569,082

INTRAVASCULAR ATRIAL FIBRILLATION TREATMENT SYSTEM AND METHOD

Final Rejection §102§103
Filed
Dec 11, 2023
Examiner
LUONG, PETER
Art Unit
3797
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
Chambertech Ltd.
OA Round
2 (Final)
69%
Grant Probability
Favorable
3-4
OA Rounds
3y 10m
To Grant
96%
With Interview

Examiner Intelligence

Grants 69% — above average
69%
Career Allow Rate
501 granted / 727 resolved
-1.1% vs TC avg
Strong +27% interview lift
Without
With
+26.9%
Interview Lift
resolved cases with interview
Typical timeline
3y 10m
Avg Prosecution
29 currently pending
Career history
756
Total Applications
across all art units

Statute-Specific Performance

§101
7.4%
-32.6% vs TC avg
§103
38.9%
-1.1% vs TC avg
§102
22.9%
-17.1% vs TC avg
§112
22.3%
-17.7% vs TC avg
Black line = Tech Center average estimate • Based on career data from 727 resolved cases

Office Action

§102 §103
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Claim Rejections - 35 USC § 102 The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention. Claim(s) 82-85, 90-91, and 95-101 is/are rejected under 35 U.S.C. 102(a)(1) as being anticipated by Scheib (US 7,575,566). Scheib discloses an ablation catheter (Fig. 1) for treating atrial arrhythmia, comprising: an elongate proximal shaft (14); and a distal ablation probe (17), which comprises: an elongate distal shaft (17) that includes a first tubular portion, a second tubular portion, and a tubular connecting end portion that connects the first and second tubular portions; and ablation electrodes (col. 5, lines 34-47), which are configured to ablate an atrial wall of a heart (col. 1, lines 54-67), and wherein, when the distal ablation probe is unconstrained: the first and the second tubular portions are straight and the tubular connecting end portions is entirely curved (Figs. 4-5), the first tubular portion runs alongside the second tubular portion (Figs. 4-5), the ablation catheter defines a curved portion that connects a proximal end of the first tubular portion to a distal end of the elongate proximal shaft (Figs. 4-5), and a best-fit plane defined by the first and the second tubular potions forms a plane-axis angle with a central longitudinal axis of the elongate proximal shaft that passes through the distal end of the elongate proximal shaft (Fig. 6), the plane-axis angle between 45 and 90 degrees (Fig. 6, col. 3, lines 52-55). With respect to claims 83-85, Scheib discloses wherein the plane-axis angle is 90 degrees (Fig. 6, col. 3, lines 52-55). With respect to claim 90, Scheib discloses wherein the first and second tubular portions are coplanar when the distal ablation probe is unconstrained (Fig. 6). With respect to claim 91, Scheib discloses wherein the first and the second tubular portions are parallel to each other when the distal probe is unconstrained (Figs. 4 and 6). With respect to claim 95, Scheib discloses wherein the distal ablation probe comprises one or more sensing electrodes (col. 5, lines 34-47). With respect to claim 96, Scheib discloses a shape memory (col. 4, lines 1-5). With respect to claims 97-99, Scheib discloses wherein when the distal ablation probe is unconstrained, wherein a central longitudinal axis of the first tubular portion intersects and forms an axis-axis angle with the central longitudinal axis of the elongate proximal shaft, the axis-axis angle between 45 and 90 degrees (Fig. 6; col. 3, lines 52-55). With respect to claim 100, Scheib discloses a sheath (62). With respect to claim 101, Scheib discloses a source of RF ablation energy (col. 4, lines 41-45). Claim Rejections - 35 USC § 103 The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. Claim(s) 92-94 is/are rejected under 35 U.S.C. 103 as being unpatentable over Scheib (US 7,575,566). Scheib discloses the subject matter substantially as claimed except for the length and distance of the tubular portion. However, Scheib discloses shape memory material (col. 4, lines 1-5) and the region can comprise more than one loop or circle (col. 3, line 49-51). Therefore, it would have been obvious to one of ordinary skill in the art to have modified the shape of Scheib as a change in shape and size is well within the skill level of one of ordinary skill in the art (MPEP 2144.04(IV)(A and B)). Claim(s) 86 is/are rejected under 35 U.S.C. 103 as being unpatentable over Scheib (US 7,575,566) in view of Gaiser et al. (US 6,200,315). Scheib discloses the subject matter substantially as claimed except for a radius of curvature of 0.25 cm – 1 cm. However, Gaiser et al. teaches in the same field of endeavor wherein the distal end of the cardiac ablation catheter has a radius of curvature which ranges from 0.5 cm to 2 cm (col. 2, lines 62-63). Therefore, it would have been obvious to one of ordinary skill in the art to have provided Scheib with the radius of curvature as taught by Gaiser et al. as it is a well known dimension used in cardiac ablation catheters. Claim(s) 87 is/are rejected under 35 U.S.C. 103 as being unpatentable over Scheib (US 7,575,566) in view of Stewart et al. (US 2002/0022839). Scheib discloses the subject matter substantially as claimed except for wherein the distal ablation probe is unconstrained, the proximal end of the first tubular portion is located at a location along the first tubular portion at a distance from a distal endpoint of the first tubular portion, the distance equal to between 40% and 60% of a length of the second tubular portion. However, Stewart et al. teaches in the same field of endeavor a shape wherein the proximal end of the first tubular portion is located at a location along the first tubular portion at a distance from a distal endpoint of the first tubular portion, the distance equal to between 40% and 60% of a length of the second tubular portion (Figs. 1C-1D). Therefore, it would have been obvious to one of ordinary skill in the art to have provided Scheib with the shape as taught by Stewart et al. as a change in shape is well within the skill level of one of ordinary skill in the art (MPEP 2144.04(IV)(B)). Claim(s) 88-89 is/are rejected under 35 U.S.C. 103 as being unpatentable over Scheib (US 7,575,566) in view of Chen (US 2018/0140347). Scheib discloses the subject matter substantially as claimed except for the greatest major and minor dimensions. However, Chen teaches in the same field of endeavor wherein the probe shape may be elliptical ([0209]). Therefore, it would have been obvious to one of ordinary skill in the art to have modified the shape of Scheib to be elliptical as a change in shape and size is well within the skill level of one of ordinary skill in the art (MPEP 2144.04(IV)(A and B)). Response to Arguments Applicant's arguments filed 11/12/2025 have been fully considered but they are not persuasive. Applicant argues the reference does not teach the first and second tubular portions are straight and the first tubular portion runs alongside the second tubular portion. However, the Examiner respectfully disagrees with the applicant. Scheib discloses in Fig. 6 wherein the first and second tubular portions are straight and the first tubular portion runs alongside the second tubular portion. The Examiner notes that applicant has failed to provide specific defined measurements for the first and second tubular portions, therefore, the portions are interpreted in its broadest reasonable interpretation. Therefore, Scheib discloses in Figs. 4-6 wherein portions that are straight, end portions that are curved, and portions that run alongside each other. Conclusion THIS ACTION IS MADE FINAL. Applicant is reminded of the extension of time policy as set forth in 37 CFR 1.136(a). A shortened statutory period for reply to this final action is set to expire THREE MONTHS from the mailing date of this action. In the event a first reply is filed within TWO MONTHS of the mailing date of this final action and the advisory action is not mailed until after the end of the THREE-MONTH shortened statutory period, then the shortened statutory period will expire on the date the advisory action is mailed, and any nonprovisional extension fee (37 CFR 1.17(a)) pursuant to 37 CFR 1.136(a) will be calculated from the mailing date of the advisory action. In no event, however, will the statutory period for reply expire later than SIX MONTHS from the mailing date of this final action. Any inquiry concerning this communication or earlier communications from the examiner should be directed to PETER LUONG whose telephone number is (571)270-1609. The examiner can normally be reached M-F 9-6. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Anhtuan T Nguyen can be reached at (571)272-4963. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /PETER LUONG/Primary Examiner, Art Unit 3797
Read full office action

Prosecution Timeline

Dec 11, 2023
Application Filed
Jan 14, 2025
Response after Non-Final Action
Jul 18, 2025
Response after Non-Final Action
Aug 08, 2025
Non-Final Rejection — §102, §103
Nov 12, 2025
Response Filed
Feb 20, 2026
Final Rejection — §102, §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12602772
SYSTEMS AND METHODS FOR RAPID NEURAL NETWORK-BASED IMAGE SEGMENTATION AND RADIOPHARMACEUTICAL UPTAKE DETERMINATION
2y 5m to grant Granted Apr 14, 2026
Patent 12599368
INFORMATION PROCESSING APPARATUS, INFORMATION PROCESSING METHOD, AND PROGRAM
2y 5m to grant Granted Apr 14, 2026
Patent 12582383
ULTRASOUND IMAGE PROCESSING METHOD, AND ULTRASOUND APPARATUS USING THE SAME
2y 5m to grant Granted Mar 24, 2026
Patent 12551124
SYSTEMS AND METHODS FOR MEASURING CAPILLARY REFILL TIME
2y 5m to grant Granted Feb 17, 2026
Patent 12544153
INDWELLING-TYPE MEDICAL DEVICE AND ENDOSCOPE SYSTEM USING THE SAME
2y 5m to grant Granted Feb 10, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

AI Strategy Recommendation

Get an AI-powered prosecution strategy using examiner precedents, rejection analysis, and claim mapping.
Powered by AI — typically takes 5-10 seconds

Prosecution Projections

3-4
Expected OA Rounds
69%
Grant Probability
96%
With Interview (+26.9%)
3y 10m
Median Time to Grant
Moderate
PTA Risk
Based on 727 resolved cases by this examiner. Grant probability derived from career allow rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month